Ventas (VTR) Price Target Increased to $62.00 by Analysts at BMO Capital Markets

Ventas (NYSE:VTR) had its price target lifted by stock analysts at BMO Capital Markets from $60.00 to $62.00 in a research note issued on Monday. The brokerage presently has a “market perform” rating on the real estate investment trust’s stock. BMO Capital Markets’ target price would indicate a potential downside of 2.45% from the stock’s current price.

A number of other research analysts also recently weighed in on the company. TheStreet downgraded Ventas from a “b” rating to a “c+” rating in a research note on Friday, October 26th. Royal Bank of Canada downgraded Ventas from an “outperform” rating to a “sector perform” rating and set a $59.00 price target on the stock. in a research note on Friday, November 2nd. ValuEngine raised Ventas from a “sell” rating to a “hold” rating in a research note on Wednesday, October 17th. Stifel Nicolaus set a $55.00 price target on Ventas and gave the stock a “hold” rating in a research note on Monday, October 29th. Finally, JPMorgan Chase & Co. started coverage on Ventas in a research note on Tuesday, October 30th. They issued a “neutral” rating and a $60.00 price objective for the company. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $57.92.

Shares of Ventas stock traded down $0.71 on Monday, hitting $63.56. 110,793 shares of the company’s stock traded hands, compared to its average volume of 1,974,819. Ventas has a one year low of $46.55 and a one year high of $65.70. The company has a debt-to-equity ratio of 1.04, a current ratio of 0.53 and a quick ratio of 0.56. The firm has a market cap of $22.91 billion, a price-to-earnings ratio of 15.61, a PEG ratio of 5.03 and a beta of 0.33.

Ventas (NYSE:VTR) last announced its earnings results on Friday, February 8th. The real estate investment trust reported $0.96 EPS for the quarter, beating the consensus estimate of $0.95 by $0.01. Ventas had a return on equity of 3.54% and a net margin of 10.93%. The company had revenue of $923.26 million for the quarter, compared to analyst estimates of $913.92 million. During the same quarter in the prior year, the company earned $1.03 EPS. The firm’s revenue for the quarter was up 3.1% compared to the same quarter last year. On average, sell-side analysts expect that Ventas will post 3.84 EPS for the current fiscal year.

In other Ventas news, EVP T Richard Riney sold 15,676 shares of the stock in a transaction on Thursday, December 6th. The stock was sold at an average price of $65.00, for a total transaction of $1,018,940.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.40% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Rational Advisors LLC bought a new position in shares of Ventas in the fourth quarter worth $34,000. Reilly Financial Advisors LLC bought a new position in shares of Ventas in the fourth quarter worth $35,000. Oregon Public Employees Retirement Fund boosted its holdings in shares of Ventas by 5,686.9% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 2,253,547 shares of the real estate investment trust’s stock worth $38,000 after acquiring an additional 2,214,605 shares during the period. Eukles Asset Management bought a new position in shares of Ventas in the fourth quarter worth $48,000. Finally, Atlas Capital Advisors LLC bought a new position in shares of Ventas in the fourth quarter worth $56,000. 86.02% of the stock is owned by institutional investors and hedge funds.

Ventas Company Profile

Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities.

Featured Article: 12b-1 Fees

Analyst Recommendations for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply